You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRCA mutation

Showing 1 - 25 of 2,994
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer With or Without BRCA Mutation

Recruiting
  • Breast Cancer
  • Androgen receptor status and BRCA mutation
  • Varanasi, UP, India
    Banaras Hindu University
Jun 2, 2022

PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

Not yet recruiting
  • BRCA Mutation
  • +2 more
  • Germinal BRCA
  • (no location specified)
Mar 3, 2023

BRCA and NACT in TNBC Patients

Completed
  • Triple-Negative Breast Cancer
  • BRCA1/2 genetic testing
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 20, 2023

Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • Dnipro, Ukraine
  • +1 more
Jun 17, 2023

Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • +7 more
  • (no location specified)
Aug 1, 2022

Quality of Sexual Function in BRCA Mutated Women

Recruiting
  • BRCA Mutation
  • +3 more
  • SFQ28 Questionnaire
  • Brescia, BS, Italy
    Federico Ferrari
Jul 10, 2022

MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion

Active, not recruiting
  • Screening Breast MRI in Patients Who Are BRCA Mutation Carriers
  • MRI
  • Optional Screening Questionnaire
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 19, 2022

Breast Cancer, Genetic Disease, BRCA2 Mutation Trial (blood sample for BRCA2 mutation detection)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • blood sample for BRCA2 mutation detection
  • (no location specified)
Jun 1, 2023

BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Columbus (Informational Intervention, Survey Administration)

Recruiting
  • BRCA1 Gene Mutation
  • BRCA2 Gene Mutation
  • Informational Intervention
  • Survey Administration
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 2, 2022

BRCA1 Mutation, BRCA2 Mutation Trial in New York, Durham, Houston (Family Letter (Standard of Care), Educational Video, Mailed

Recruiting
  • BRCA1 Mutation
  • BRCA2 Mutation
  • Family Letter (Standard of Care)
  • +3 more
  • New York, New York
  • +2 more
Aug 12, 2022

Dietary Modification, BRCA1 Mutation, BRCA2 Mutation Trial in Milano (Dietary intervention)

Completed
  • Dietary Modification
  • +3 more
  • Dietary intervention
  • Milano, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Sep 27, 2021

Pancreatic Ductal Adenocarcinoma Trial in Israel, United States (The risk assessment questionnaire, Blood specimens, tumor

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • The risk assessment questionnaire
  • +2 more
  • Basking Ridge, New Jersey
  • +12 more
Dec 22, 2022

Prostate Cancer Trial in Toronto (MS3TMRI / TRUS Guided Biopsy)

Recruiting
  • Prostate Cancer
  • MS3TMRI / TRUS Guided Biopsy
  • Toronto, Ontario, Canada
    Sunnybrook Odette Cancer Centre
May 5, 2022

Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +2 more
Dec 21, 2022

Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)

Recruiting
  • Breast Cancer
  • Genetic Predisposition
  • Genetic predisposition to breast cancer
  • Rome, Italy
  • +1 more
May 4, 2023

Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or

Recruiting
  • Ovarian Cancer
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Jul 13, 2022

    Frequency of Occult Breast Cancer After Prophylactic Mastectomy

    Recruiting
    • Genetic Predisposition
    • +3 more
    • Histopathological confirmation
    • Karachi, Sindh, Pakistan
      Aga Khan University Hospital
    Mar 15, 2023

    BRCA Mutation, PALB2 Gene Mutation, Ductal Carcinoma in Situ Trial in Italy (drug, other, behavioral)

    Not yet recruiting
    • BRCA Mutation
    • +3 more
    • Tamoxifen 10 Mg Tablet
    • +2 more
    • Genoa, Italy
    • +3 more
    Sep 11, 2023

    BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer Trial in Providence (Talazoparib Oral Capsule)

    Active, not recruiting
    • BRCA1 Mutation
    • +4 more
    • Talazoparib Oral Capsule
    • Providence, Rhode Island
    • +1 more
    Nov 30, 2022

    Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

    Not yet recruiting
    • Metastatic Solid Tumor
    • +4 more
    • San Francisco, California
      University of California, San Francisco
    Jan 12, 2023

    BRCA1/2 Flu Vaccine

    Active, not recruiting
    • BRCA1 Mutation
    • BRCA2 Mutation
    • Seasonal influenza vaccine
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Aug 16, 2022

    The Pancreas Interception Center for Early Detection,

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +12 more
    • Data collection
    • Tampa, Florida
      Moffitt Cancer Center
    Jan 11, 2023

    Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

    Recruiting
    • Stage I Breast Cancer
    • +7 more
    • Baltimore, Maryland
    • +6 more
    Nov 11, 2022

    An Imaging Study of FCH-PET-CT in Prostate Cancer andBRCA Gene

    Recruiting
    • Prostate Cancer
    • +2 more
    • MRI pelvis or CT imaging
    • +2 more
    • London, Sutton, Surrey, United Kingdom
      Cancer Genetics Unit, Royal Marsden Hospital
    Mar 30, 2022

    Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

    Not yet recruiting
    • Breast Cancer
    • +7 more
    • (no location specified)
    Sep 26, 2023